Multiple Myeloma: A Continuously Evolving Disease.

The recent trend of translational research has introduced a paradigm shift of our understanding of the applicability of bench top research. Translational research funnels in the outcomes of various techniques used in basic research and utilizes them for the benefit of patients in clinical research. Using the example of multiple myeloma, the aim of this article is to shed light on how our accumulated knowledge in different areas of basic research and application of cutting-edge technologies is leveraged in diagnosis, disease gradation, and prognosis. Patients suffering from this incurable disease benefit from the outcome of this research and experience significantly extended progress-free survival, which was beyond imagination even a few decades ago. The disease is currently managed by well-established and continuously evolving treatment options for patients, thus keeping their hope alive for a permanent cure.